NCT03146676

Recruiting

The Ohio State University Dermatology Biorepository

Ohio State University Source

Compare

Other study identifiers

Sponsor study identifier

2010H0331

Study Type

observational

Estimated enrollment

175

Locations

1 country

Sites

1

Timeline

Study Start

April 19, 2017

Actual (reported)

Primary Completion

December 31, 2030

Estimated

Planned date reported by the registry; this milestone is not confirmed as achieved.

Study Completion

December 31, 2030

Estimated

Planned date reported by the registry; this milestone is not confirmed as achieved.

Brief Summary

This study will create and extend a source of clinical specimens for the future study of inflammatory skin disorders.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: recruiting
Estimated enrollment: 175 participants
Study completion date: December 31, 2030
Estimated
Planned date reported by the registry; this milestone is not confirmed as achieved.
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
April 19, 2017
Actual (reported)
First Submitted
May 5, 2017
Actual (reported)
First Posted
May 10, 2017
Actual (reported)
Primary Completion
December 31, 2030
Estimated
Planned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
December 31, 2030
Estimated
Planned date reported by the registry; this milestone is not confirmed as achieved.

Last Updated: February 27, 2026
Status Verified: February 2026
Last Update Submitted: February 24, 2026

Conditions

Hidradenitis Suppurativa

Outcome Measures

Primary Outcomes (1)

Source of clinical specimens for the future study of neoplastic and inflammatory skin disorders
5 years

Eligibility Criteria

Sexall

Healthy VolunteersYes

Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

Sampling MethodProbability Sample

Study Population

Any person that meets the inclusion/exclusion criteria

You may qualify if:

Seen by an Ohio State University (OSU) Dermatology provider on the main University Hospital campus, including the James Cancer Hospital, OSU Dermatology East, OSU Dermatology at the Ohio State Eye and Ear Institute, Martha Morehouse Medical Pavilion, and OSU Dermatology at Upper Arlington after the date of approval of this protocol

Sponsors & Collaborators

Ohio State University
Otherlead

Study Sites (1)

OSU Dermatology West

Columbus, Ohio, 43215, United States

RECRUITING

Alison RocchiCONTACT614-685-0251 Alison.Wandling@osumc.edu

Kristina SusiCONTACT614-814-1277 Kristina.Susi@osumc.edu

Benjamin Kaffenberger, MDPRINCIPAL INVESTIGATOR

Biospecimen

Retention: SAMPLES WITH DNA

Skin Tissue, Peripheral blood mononuclear cells, skin swabs, and saliva.

MeSH Terms

Conditions

Hidradenitis Suppurativa

Condition Hierarchy (Ancestors)

Skin Diseases, BacterialBacterial InfectionsBacterial Infections and MycosesInfectionsSkin Diseases, InfectiousSuppurationSkin DiseasesSkin and Connective Tissue DiseasesHidradenitisSweat Gland Diseases

Study Officials

Benjamin Kaffenberger, MD
Dermatologist
PRINCIPAL INVESTIGATOR

Central Study Contacts

Alison Rocchi

CONTACT

614-685-0251 alison.wandling@osumc.edu

Kristina Susi

CONTACT

614-814-1277

Study Design

Study Type: observational
Observational Model: OTHER
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Dermatologist

Study Record Dates

First Submitted

May 5, 2017

First Posted

May 10, 2017

Study Start

April 19, 2017

Actual (reported)

Primary Completion

December 31, 2030

Estimated

Planned date reported by the registry; this milestone is not confirmed as achieved.

NCT05830149

Safety and Treatment of Cryoinsufflation in Treatment of Hidradenitis Suppurativa

Not ApplicableTerminated

NCT02805595

Effect of Sclerotherapy on Fistulas and Sinus Tracts in Hidradenitis Suppurativa

Phase 2Completed

NCT02781818

A Randomized Controlled Trial Evaluating the Efficacy of Intralesional Triamcinolone in Hidradenitis Suppurativa.

Not ApplicableCompleted

NCT02695212

Single Center Study of Apremilast for the Treatment of Hidradenitis Suppurativa

Phase 2Completed

NCT05255575

A Single Center, Prospective Clinical Trial of Intravenous Ertapenem in the Treatment of Hurley Stage II or III Hidradenitis Suppurativa

Withdrawn

NCT03289585

A National Registry For Patients With Hidradenitis Suppurativa

Completed

Ability to provide informed consent, or parent or legal guardian capable of providing consent for child or mentally handicapped individuals

Willingness to participate in a research study.

You may not qualify if:

Inability to provide informed consent

Contact the study team to confirm eligibility.

Kristina.Susi@osumc.edu

Study Completion

December 31, 2030

Estimated

Planned date reported by the registry; this milestone is not confirmed as achieved.

Last Updated

February 27, 2026

Record last verified: 2026-02

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT03146676
Data provider: ClinicalTrials.gov
Source updated: 2026-02-27
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:28:44 UTC

Locations

US(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Biospecimen

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations